Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Gastric surgery reduces ghrelin levels in the morbidly obese

Ghrelin, a powerful appetite stimulant, is reduced in morbidly obese patients who have undergone gastric surgery, finds a study in the journal Archives of Surgery, suggesting a possible explanation for the rapid loss of hunger and weight in such patients who have had gastric bypass surgery.

News image

fiogf49gjkf04

Ghrelin, which is produced mainly in the stomach, is a potent orexigen or appetite inducing hormone that has been shown to be elevated in states of hunger, but to decline rapidly following a meal.

Researchers from Emory University School of Medicine, Atlanta, USA, were interested to investigate whether the early alterations in ghrelin levels observed in morbidly obese patients undergoing weight reduction surgery may be due to gastric partitioning.

They studied 34 patients who underwent Roux-en-Y gastric bypass with a completely divided gastroplasty to create a 15 mL vertically orientated gastric pouch.

In addition, 8 other patients who underwent less drastic gastric bypass procedures not involving complete division of the stomach were also studied. These included 4 vertical banded gastroplasties and 4 anti-reflux surgical procedures.

A lean control group of 6 additional patients undergoing anti-reflux surgery was also included in the study.

Gastric bypass surgery caused ghrelin levels to drop by almost a third
Archives of surgery

In each case plasma samples were obtained before surgery and immediately after surgery, while in a sub-study, plasma was collected after Roux-en-Y limb formation and after dividing the stomach in order to identify any changes in plasma ghrelin levels.

The researchers found that in the patients not undergoing the gastric bypass procedure (i.e. the vertical banded gastroplasty group and all patients undergoing anti-reflux surgery) there were no significant changes in ghrelin levels following surgery.

This was in marked contrast to the gastric bypass group, where mean preoperative ghrelin levels dropped from 355 pg/mL to 246 pg/mL postoperatively.

Lead researcher Dr Edward Lin said, "This is the first time we have found that different types of weight-loss surgeries affect ghrelin levels in humans. Compared with morbidly obese humans, lean controls had significantly higher plasma ghrelin levels at baseline."

"When the stomach is divided, forming a small gastric pouch, the ghrelin levels are significantly reduced early after the surgery is performed. Other mechanisms can make you hungry, but ghrelin is one of the most potent hunger stimulants."

He added, "This study shows that surgically induced weight loss with Roux-en-Y gastric bypass in these patients appears to cause long-term, if not permanent, suppression of ghrelin secretions that is not associated with other weight-loss procedures and may explain, in part, the loss of hunger sensation and rapid weight loss observed following gastric bypass surgery."

Arch Surg 2004; 139 (7): 780 - 784
22 July 2004

Go to top of page Email this page Email this page to a colleague

 19 February 2018 
Screening colonoscopy in the right and left colon
 19 February 2018 
NAFLD prevalence in the USA
 19 February 2018 
Fructans in children with IBS

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us